Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMERICANO: Multimodal Therapy in Hemodialysis
NCT02418065Phase 3Unknown
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Dec 2013
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of testosterone, omega-3 fatty acid in protein-energy wasting (PEW), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Status: unknown.
02
Drugs
testosteroneomega-3 fatty acid
03
Conditions
protein-energy wasting (PEW)
Beyond the preview
Go deeper on NCT02418065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02418065.